Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2019 Dec 12;47(4):947–957. doi: 10.1007/s00259-019-04530-1

Fig. 5.

Fig. 5

A 65-year-old woman with G2 duodenum NET, had extensive involvement of liver. (A-C) Baseline 68Ga-DOTATATE PET/CT before administration with 1.96 GBq 177Lu-DOTA-EB-TATE. (D-F) 2 months post-therapy 68Ga-DOTATATE PET/CT showed diffuse decreased uptake in primary tumor and liver metastases from 21.3 to 10.8 (lower arrow) and 38.3 to 22.2 (upper arrows), respectively.